MICROMET, INC.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | FY09 | |
|---|---|---|---|
| Revenue | $21.9M | $28.7M | $21.0M |
| Operating income | −$81.6M | −$42.1M | −$49.4M |
| Net income | −$74.2M | −$50.1M | −$56.1M |
| Total assets | $178.1M | $242.3M | — |
| Total liabilities | — | — | — |
| Equity | $111.5M | $174.6M | $66.8M |
| EPS (diluted) | — | — | — |
| Shares out. | 92.4M | 91.2M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- −372.1%
- Net margin
- −338.4%
- Return on equity
- −66.5%
- Return on assets
- −41.6%
- Return on capital (ROCE)
- −60.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.21
- Revenue growth (YoY)
- −23.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Accruals / assets
- −8.0%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 1 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsMar 7, 2012
- Entered a material agreement · Modified shareholder rights · Director / officer change · Other material eventJan 27, 2012
- Results of operationsNov 8, 2011
- Results of operationsAug 4, 2011
- Entered a material agreement · Other material eventJul 15, 2011
- Amended charter or bylaws · Shareholder voteJun 28, 2011
- Director / officer change · Other material eventJun 16, 2011
- Results of operationsMay 10, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AAMENDMENT NO. 4Feb 14, 2013
- SC 13G/AFORM SC 13G/AMar 28, 2012
- AWAPPLICATION FOR WITHDRAWALMar 20, 2012
- 15-12GFORM 15Mar 19, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- EFFECTMar 14, 2012
- RWAPPLICATION FOR WITHDRAWALMar 14, 2012
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.